These two great companies are selling Biel’s products,
Walgreens Boots Alliance is the first global pharmacy-led, health and wellbeing enterprise in the world. Our purpose is to help people across the world lead healthier and happier lives.
Walgreens Boots Alliance was created through the combination of Walgreens and Alliance Boots in December 2014. This transaction brought together two leading companies with iconic brands, complementary geographic footprints, shared values and a heritage of trusted healthcare services through pharmaceutical wholesaling and community pharmacy care, dating back more than 100 years.
The Company, with a presence in more than 25* countries, employs over 370,000* people and is the largest retail pharmacy, health and daily living destination in the USA and Europe, and (including equity method investments) is: the global leader in pharmacy-led, health and wellbeing retail with over 13,200* stores in 11* countries one of the largest global pharmaceutical wholesale and distribution networks with over 350* distribution centers delivering to more than 200,000† pharmacies, doctors, health centers and hospitals each year in 19* countries
one of the world’s largest purchasers of prescription drugs and many other health and wellbeing products
Walgreens Boots Alliance Reports Fiscal 2015 Third Quarter Results; Board Names Stefano Pessina as CEO
Adjusted third quarter net earnings per diluted share increase 22.9 percent to $1.02 compared with the year-ago period; GAAP net earnings per diluted share increase 59.5 percent to $1.18
Adjusted third quarter net earnings attributable to Walgreens Boots Alliance increase 39.9 percent to $1.1 billion compared with the year-ago period; GAAP net earnings attributable to Walgreens Boots Alliance increase 82.4 percent to $1.3 billion
Third quarter sales increase 48.4 percent to $28.8 billion compared with the year-ago period
Retail Pharmacy USA division comparable drugstore sales increase 6.3 percent
Free cash flow totals $1.6 billion in the quarter while GAAP operating cash flow totals $1.8 billion
Company increases fiscal 2015 full year adjusted net earnings guidance to $3.70 to $3.80 per diluted share, and reaffirms fiscal 2016 adjusted net earnings per diluted share goal
Quarterly dividend to increase 6.7 percent to 36 cents per share
B. Braun Medical Ltd is a member of the B. Braun Group, one of the world's leading healthcare companies. B. Braun manufactures and distributes on a global basis, employing 54,000 people in 62 countries and achieves a turnover of 5.43 billion euros.
Everything I say and write is my opinion and my opinion only. Do your own due diligence when investing
